BOLT Bolt Biotherapeutics, Inc.
$6.37▼ -3.34%
Healthcare
Other
Volume 176.4K
Avg Volume (10D) 1.35M
Key Metrics & Fundamentals
Market Cap
$15.01M
P/E Ratio
–
Div Yield
0.00%
52W Range
3.10 - 7.78
% vs 50 MA
61.74%
% vs 200 MA
41.52%
RSI-14
76.8
MACD Histogram
+0.2800
Beta (1Y vs SPY)
0.61
Free Cash Flow
-$6.55M
Gross Rev
$5,000
Gross Profit
$5,000
EBITDA
-$6.59M
COGS
–
Operating Exp
$7.57M
Operating Income
-$7.57M
EBIT
-$7.57M
Pretax Income
-$7.72M
Net Income
-$7.72M
EPS (Diluted)
-4.57
Price & Volume History
Loading chart…
Recent News
Top Midday Gainers
MT Newswires · Oct 23, 2026 2:35 PM ET
Bolt Biotherapeutics Announces Acquisition of Prana Therapies and $120 Million Concurrent Private Placement to Advance PRA-216 in Multiple High-Value Inflammatory Indications
GlobeNewswire · Oct 23, 2026 9:08 AM ET
Bolt Biotherapeutics, Inc. (BOLT) Reports Q2 Loss, Misses Revenue Estimates
Zacks · Aug 11, 2026 5:45 PM ET
Bolt Biotherapeutics Inc.: Q2 Earnings Snapshot
Associated Press · Aug 11, 2026 4:41 PM ET
Bolt Biotherapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
GlobeNewswire · Aug 11, 2026 4:05 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See BOLT's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.